Conditioned pain modulation: A predictor for development and treatment of neuropathic pain

Current Pain and Headache Reports

Volumn 17, Issue 9, 2013, Pages

  Granovsky, Yelena ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Central sensitization; Chronic pain; Conditioned pain modulation (CPM); Neuropathic pain; Pain facilitation; Pain inhibition; Personalized pain medicine; Psychophysics

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; GABAPENTIN; KETAMINE; MORPHINE; OXYCODONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFERENT NERVE GROUP 1; ANALGESIA; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONDITIONED PAIN MODULATION; CONDITIONING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LABORATORY TEST; MONARTHRITIS; MONONEUROPATHY; NERVE FIBER C; NERVE INJURY; NERVE STIMULATION; NEUROMODULATION; NEUROPATHIC PAIN; NEUROPHYSIOLOGY; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PERCEPTIVE THRESHOLD; PERSONALIZED MEDICINE; POSTOPERATIVE PAIN; PREDICTION; PREOPERATIVE EVALUATION; PSYCHOPHYSICS; SENSITIVITY AND SPECIFICITY; CENTRAL NERVOUS SYSTEM SENSITIZATION; NEURALGIA; PAIN MEASUREMENT; PHYSIOLOGY; PROCEDURES; METHODOLOGY; REVIEW;

CENTRAL NERVOUS SYSTEM SENSITIZATION; CONDITIONING (PSYCHOLOGY); HUMANS; NEURALGIA; PAIN MEASUREMENT;

EID: 84881293231     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-013-0361-8     Document Type: Article

References (92)

1. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289-305. (Pubitemid 41752987)
2. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573-81.
3. Bril V, England J, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PMR. 2011;3:345-52.
4. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113-e88.
5. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807-19.
6. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3-14.
7. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630-5. (Pubitemid 351620320)
8. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959-64. (Pubitemid 29255720)
9. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci U S A. 1999;96:7687-92. (Pubitemid 29328341)
10. Coderre TJ, Katz J. Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain. Behav Brain Sci. 1997;20:404-19. (Pubitemid 28125803)
11. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain. 1976;6:305-27. (Pubitemid 9205925)
12. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain. 1979;6:283-304. (Pubitemid 9205924)
13. Gammon GD, Starr I. Studies of the relief of pain by counterirritation. J Clin Invest. 1941;20:13-20.
14. • Yarnitsky D, Arendt-Nielsen L, Bouhassira D, et al. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain. 2010;14:339. CPM is a recommended terminology for the DNIC assessment in humans.
15. Arendt-Nielsen L, Yarnitsky D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J Pain. 2009;10:556-72.
16. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44:293-9.
17. • Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011;13:513-20. Patients with these chronic pain disorders show signs of central sensitization and abnormal endogenous pain modulation.
18. Kosek E, Hansson P. Modultory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia and healthy subjects. Pain. 1997;70:41-51. (Pubitemid 27128296)
19. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain. 1997;13:189-96. (Pubitemid 27524077)
20. Price DD, Staud R. Neurobiology of fibromyalgia syndrome. J Rheumatol Suppl. 2005;75:22-8. (Pubitemid 41113955)
21. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain. 2000;88:69-78.
22. Quante M, Hille S, Schofer MD, et al. Noxious counterirritation in patients with advanced osteoarthritis of the knee reduces MCC but not SII pain generators: A combined use of MEG and EEG. J Pain Res. 2008;1:1-8.
23. Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149:573-81.
24. Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010;6:599-606.
25. •• Graven-Nielsen T, Wodehouse T, Langford RM, et al. Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement. Arthritis Rheum. 2012;64:2907-16. CPM has been restored after the surgery, in parallel with pain alleviation.
26. Sandrini G, Rossi P, Milanov I, et al. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia. 2006;26:782-9. (Pubitemid 43882986)
27. Pielsticker A, Haag G, Zaudig M, et al. Impairment of pain inhibition in chronic tension-type headache. Pain. 2005;118:215-23. (Pubitemid 41566602)
28. Buchgreitz L, Egsgaard LL, Jensen R, et al. Abnormal pain processing in chronic tension-type headache: a high-density EEG brain mapping study. Brain. 2008;131:3232-8.
29. Nahman-Averbuch H, Granovsky Y, Coghill RC, et al. Waning of Conditioned Pain Modulation: A Novel Expression of Subtle Pronociception in Migraine. Headache. 2013 Apr 17 [Epub ahead of print].
30. Chang L. Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder? Gastroenterol Clin North Am. 2005;34:271-9. (Pubitemid 40615956)
31. Song GH, Venkatraman V, Ho KY, et al. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain. 2006;126:79-90. (Pubitemid 44751957)
32. King C, Wong F, Currie T, et al. Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain. 2009;143:172-8.
33. • Daenen L, Nijs J, Roussel N, et al. Dysfunctional pain inhibition in patients with chronic whiplash-associated disorders: an experimental study. Clin Rheumatol. 2013;32:23-31. Chronic whiplash pain is associated with less efficient CPM.
34. •• van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain. 2010;11:408-19. This review summarizes recent findings on CPM with a specific focus on sex, age, and ethnic differences in CPM effects and psychological mediators, such as attention, expectation, and pain catastrophizing.
35. •• Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23:611-5. Less efficient CPM is associated with higher pain morbidity and vice versa.
36. •• Lewis GN, Rice DA, McNair PJ. Conditioned pain modulation in populations with chronic pain: a systematic review and meta-analysis. J Pain. 2012;13:936-44. This review compared the efficacy of conditioned pain modulation between chronic pain and healthy populations.
37. •• De Felice M, Sanoja R, Wang R, et al. Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain. Pain. 2011;152:2701-9. Engagement of descending inhibition protects neuropathic pain transition from acute to chronic.
38. Nahman-Averbuch H, Yarnitsky D, Granovsky Y, et al. Pronociceptive pain modulation in patients with painful chemotherapy-induced polyneuropathy. J Pain Symptom Manage. 2011;42:229-38.
39. Aasvang EK, Brandsborg B, Christensen B, et al. Neurophysiological characterization of postherniotomy pain. Pain. 2008;137:173-81. (Pubitemid 351802246)
40. Vilholm OJ, Cold S, Rasmussen L, et al. Sensory function and pain in a population of patients treated for breast cancer. Acta Anaesthesiol Scand. 2009;53:800-6.
41. Tuveson B, Leffler AS, Hansson P. Heterotopic noxious conditioning stimulation (HNCS) reduced the intensity of spontaneous pain, but not of allodynia in painful peripheral neuropathy. Eur J Pain. 2007;11:452-62. (Pubitemid 46366771)
42. Tuveson B, Leffler AS, Hansson P. Influence of heterotopic noxious conditioning stimulation on spontaneous pain and dynamic mechanical allodynia in central post-stroke pain patients. Pain. 2009;143:84-91.
43. Leonard G, Goffaux P, Mathieu D, et al. Evidence of descending inhibition deficits in atypical but not classical trigeminal neuralgia. Pain. 2009;147:217-23.
44. Witting N, Svensson P, Jensen TS. Differential recruitment of endogenous pain inhibitory systems in neuropathic pain patients. Pain. 2003;103:75-81. (Pubitemid 36579087)
45. Roosink M, Renzenbrink GJ, Buitenweg JR, et al. Somatosensory symptoms and signs and conditioned pain modulation in chronic post-stroke shoulder pain. J Pain. 2011;12:476-85.
46. Bouhassira D, Danziger N, Attal N, et al. Comparison of the pain suppressive effects of clinical and experimental painful conditioning stimuli. Brain. 2003;126:1068-78. (Pubitemid 36522950)
47. Danziger N, Weil-Fugazza J, Le Bars D, et al. Alteration of descending modulation of nociception during the course of monoarthritis in the rat. J Neurosci. 1999;19:2394-400. (Pubitemid 29133414)
48. Danziger N, Gautron M, Le Bars D, et al. Activation of diffuse noxious inhibitory controls (DNIC) in rats with an experimental peripheral mononeuropathy. Pain. 2001;91:287-96. (Pubitemid 32241150)
49. Bouhassira D, Le Bars D, Villanueva L. Heterotopic activation of A delta and C fibres triggers inhibition of trigeminal and spinal convergent neurones in the rat. J Physiol. 1987;389:301-17. (Pubitemid 17115799)
50. Ochoa JL, Yarnitsky D. Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes. Ann Neurol. 1993;33:465-72. (Pubitemid 23143029)
51. Cline MA, Ochoa J, Torebjörk HE. Chronic hyperalgesia and skin warming caused by sensitized C nociceptors. Brain. 1989;112:621-47. (Pubitemid 19151162)
52. Woolf CJ, Wall PD. Chronic peripheral nerve section diminishes the primary afferent A-fibre mediated inhibition of rat dorsal horn neurones. Brain Res. 1982;242:77-85. (Pubitemid 12088937)
53. Miletic G, Miletic V. Long-term changes in sciatic-evoked A-fiber dorsal horn field potentials accompany loose ligation of the sciatic nerve in rats. Pain. 2000;84:353-9. (Pubitemid 30074238)
54. Pertovaara A, Kalmari J. Neuropathy reduces viscero-somatic inhibition via segmental mechanisms in rats. Neuroreport. 2002;13:1047-50. (Pubitemid 34587738)
55. El-Khoury C, Hawwa N, Baliki M, et al. Attenuation of neuropathic pain by segmental and supraspinal activation of the dorsal column system in awake rats. Neuroscience. 2002;112:541-53. (Pubitemid 34634149)
56. Kohama I, Ishikawa K, Kocsis JD. Synaptic reorganization in the substantia gelatinosa after peripheral nerve neuroma formation: aberrant innervation of lamina II neurons by Ab afferents. J Neurosci. 2000;20:1538-49. (Pubitemid 30220432)
57. Malmberg AB, Chen C, Tonegawa S, et al. Preserved acute pain and reduced neuropathic pain in mice lacking PKCg. Science. 1997;278:279-83. (Pubitemid 27450873)
58. Ma W, Eisenach JC. Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice. Brain Res. 2003;970:110-8. (Pubitemid 36423186)
59. Peters ML, Schmidt AJ, Van den Hout MA, et al. Chronic back pain, acute postoperative pain and the activation of diffuse noxious inhibitory controls (DNIC). Pain. 1992;50:177-87.
60. Leffler AS, Hansson P, Kosek E. Somatosensory perception in patients suffering from long-term trapezius myalgia at the site overlying the most painful part of the muscle and in an area of pain referral. Eur J Pain. 2003;7:267-76. (Pubitemid 36565928)
61. Witting N, Svensson P, Arendt-Nielsen L, et al. Differential effect of painful heterotopic stimulation on capsaicin-induced pain and allodynia. Brain Res. 1998;801:206-10. (Pubitemid 28401665)
62. Pud D, Granovsky Y, Yarnitsky D. The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain. 2009;144:16-9.
63. De Broucker T, Cesaro P, Willer JC, et al. Diffuse noxious inhibitory controls in man. Involvement of the spinoreticular tract. Brain. 1990;113:1223-34. (Pubitemid 20267482)
64. Perrotta A, Serpino C, Cormio C, et al. Abnormal spinal cord pain processing in Huntington's disease. The role of the diffuse noxious inhibitory control. Clin Neurophysiol. 2012;123:1624-30.
65. Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2009;80:24-8.
66. Granovsky Y, Schlesinger I, Fadel S, et al. Asymmetric pain processing in Parkinson's disease. Eur J Neurol. 2013 May 24 [Epub ahead of print].
67. Granot M. Can we predict persistent postoperative pain by testing preoperative experimental pain? Curr Opin Anaesthesiol. 2009;22:425-30.
68. Bisgaard T, Klarskov B, Rosenberg J. Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain. 2001;90:261-9. (Pubitemid 32162948)
69. Granot M, Lowenstein L, Yarnitsky D, et al. Postcesarean section pain prediction by preoperative experimental pain assessment. Anesthesiology. 2003;98:1422-6. (Pubitemid 36622476)
70. Pan PH, Coghill R, Houle TT, et al. Multifactorial preoperative predictors for postcesarean section pain and analgesic requirement. Anesthesiology. 2006;104:417-25.
71. Weissman-Fogel I, Granovsky Y, Crispel Y, et al. Enhanced presurgical pain temporal summation response predicts post-thoracotomy pain intensity during the acute postoperative phase. J Pain. 2009;10:628-36.
72. Abrishami A, Chan J, Chung F, et al. Preoperative pain sensitivity and its correlation with postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology. 2011;114:445-57.
73. Brandsborg B, Dueholm M, Kehlet H, et al. Mechanosensitivity before and after hysterectomy: a prospective study on the prediction of acute and chronic postoperative pain. Br J Anaesth. 2011;107:940-7.
74. Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138:22-8.
75. •• Wilder-Smith OH, Schreyer T, Scheffer GJ, et al. Patients with chronic pain after abdominal surgery show less preoperative endogenous pain inhibition and more postoperative hyperalgesia: a pilot study. J Pain Palliat Care Pharmacother. 2010;24:119-28. Chronic post-opertive pain relates to poorer pre-operative inhibitory pain modulation (DNIC), and to greater post-operative degree, persistence, and spread of hyperalgesia.
76. Landau R, Kraft JC, Flint LY, et al. An experimental paradigm for the prediction of Post-Operative Pain (PPOP). J Vis Exp. 2010;35. doi: 10.3791/1671.
77. Chitour D, Dickenson AH, Le Bars D. Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC). Brain Res. 1982;236:329-37. (Pubitemid 12132555)
78. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol. 2006;80:53-83. (Pubitemid 44692016)
79. Lu Y, Perl ER. Selective action of noradrenaline and serotonin on neurones of the spinal superficial dorsal horn in the rat. J Physiol. 2007;582:127-36. (Pubitemid 46993566)
80. Jasmin L, Boudah A, Ohara PT. Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception. J Comp Neurol. 2003;460:38-55. (Pubitemid 36438276)
81. Vogel C, Mössner R, Gerlach M, et al. Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci. 2003;23:708-15. (Pubitemid 36139570)
82. Smith T, Nicholson RA. Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc Health Risk Manag. 2007;3:833-44.
83. Iyengar S, Webster AA, Hemrick-Luecke SK, et al. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther. 2004;311:576-84. (Pubitemid 39391542)
84. •• Yarnitsky D, Granot M, Nahman-Averbuch H, et al. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153:1193-8. Patients with less efficient CPM gain more analgesia from SNRIs, e.g. duloxetine.
85. Olson VG, Heusner CL, Bland RJ, et al. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science. 2006;311:1017-20. (Pubitemid 43271731)
86. Bohn LM, Xu F, Gainetdinov RR, et al. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci. 2000;20:9040-5. (Pubitemid 32042905)
87. Reimann W, Schlütz H, Selve N. The antinociceptive effects of morphine, desipramine, and serotonin and their combinations after intrathecal injection in the rat. Anesth Analg. 1999;88:141-5. (Pubitemid 29025162)
88. Pettersen VL, Zapata-Sudo G, Raimundo JM, et al. The synergistic interaction between morphine and maprotiline after intrathecal injection in rats. Anesth Analg. 2009;109:1312-7.
89. Suzuki R, Dickenson AH. Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury. Exp Neurol. 2006;198:72-80. (Pubitemid 43243746)
90. Lavand'homme P, Roelants F. Effect of a low dose of ketamine on postoperative pain after elective Cesarean delivery according to the presence of a preoperative temporal summation. SOAP abstract A-258, 2009.
91. • Eisenberg E, Midbari A, Haddad M, et al. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects. Pain. 2010;151:104-9. Healthy patients with enhanced TS gain more pain relief on cold pressor by oxycodone.
92. •• Olesen SS, Graversen C, Bouwense SA, et al. Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis. PLoS One. 2013;8:e57963. Quantitative sensory testing predicts analgesic effect of pregabalin in patients with painful chronic pancreatitis.